Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis

BACKGROUND: Neonatal hepatitis refers to a heterogeneous group of disorders, caused by many factors including cytomegalovirus infection, revealing similar morphologic changes in the liver of an infant less than 3 months of age. Approximately 40% of cholestasis in infants is due to neonatal hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkan, Tanju Basarir, Mistik, Resit, Dikici, Bunyamin, Nazlioglu, Hülya Ozturk
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847446/
https://www.ncbi.nlm.nih.gov/pubmed/17355631
http://dx.doi.org/10.1186/1471-230X-7-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847446/
https://www.ncbi.nlm.nih.gov/pubmed/17355631
http://dx.doi.org/10.1186/1471-230X-7-9

Ejemplares similares